Multiple sclerosis clinical trials – fighting for a cure
To support the Multiple Sclerosis Trust’s Awareness Week 2016 the ISRCTN registry is exploring what’s new in the world of multiple sclerosis related clinical trials, and taking a look at some of the innovative studies in the registry.
Multiple sclerosis (MS) is the most common disabling neurological condition affecting young adults, with around 2.5 million cases worldwide, and around 6,000 new diagnosesin the UK every year. It’s an inflammatory demyelinating condition of the central nervous system (CNS) that’s characterized by the destruction of myelin – a fatty substance insulating nerve fibers – resulting in the formation of scars (known as lesions or plaques) which disrupt the transmission of impulses.
No hay comentarios:
Publicar un comentario